Evidence map›Paper›PMID 28575043›Full record

ArticlePLoS neglected tropical diseases2017

Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.

Carla Cangalaya, Javier A Bustos, Juan Calcina, Ana Vargas-Calla, Javier Mamani, Diego Suarez, Gianfranco Arroyo, Armando E Gonzalez, Juan Chacaltana, Cristina Guerra-Giraldez and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Large Cohort of Neurocysticercosis in Shandong Province, Eastern China, 1997-2015.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2019
    Article
  9. MicroRNAs inFrontiers in microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Carla CangalayaLaboratorio de Inmunopatología en Neurocisticercosis, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID http://orcid.org/0000-0002-3525-8445
Javier A BustosUnidad de Cisticercosis, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Juan CalcinaFacultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Ana Vargas-CallaFacultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Javier MamaniFacultad de Medicina Veterinaria y Zootecnia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Diego SuarezFacultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.
Gianfranco ArroyoUnidad de Cisticercosis, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Armando E GonzalezFacultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Juan ChacaltanaDepartamento de Diagnóstico por imágenes, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Cristina Guerra-GiraldezLaboratorio de Inmunopatología en Neurocisticercosis, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
Siddhartha MahantyLaboratorio de Inmunopatología en Neurocisticercosis, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
Theodore E NashLaboratorio de Inmunopatología en Neurocisticercosis, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru.
Héctor H GarcíaUnidad de Cisticercosis, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Cysticercosis Working Group in Peru
National University of San Marcos · PEUniversidad Peruana Cayetano Heredia · PEInstituto Nacional de Ciencias NeurológicasNational Institutes of Health · US

Funding

Studies of neurocysticercosis and animal cestode infectionsZIAAI000846 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NASH, THEODORE · 2009 to 2020
$9.5M
Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
Use of bisphosphonates to reduce the calcification process in animal models of cysticercosisR01AI116456 · NIAID · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI BUSTOS, JAVIER A · 2015 to 2019
$651k
FIC NIH HHS D43 TW001140NIAID NIH HHS R01 AI116456
6 · The paper itself

Abstract

backgroundThe onset of anthelmintic treatment of neurocysticercosis (NCC) provokes an acute immune response of the host, which in human cases is associated with exacerbation of neurological symptoms. This inflammation can occur at the first days of therapy. So, changes in the brain cysts appearance may be detected by medical imaging. We evaluated radiological changes in the appearance of brain cysts (enhancement and size) on days two and five after the onset of antiparasitic treatment using naturally infected pigs as a model for human NCC. METHODS AND

resultsContrast T1-weighted magnetic resonance imaging with gadolinium was performed before and after antiparasitic treatment. Eight NCC-infected pigs were treated with praziquantel plus albendazole and euthanized two (n = 4) and five (n = 4) days after treatment; another group of four infected pigs served as untreated controls. For each lesion, gadolinium enhancement intensity (GEI) and cyst volume were measured at baseline and after antiparasitic treatment. Volume and GEI quantification ratios (post/pre-treatment measures) were used to appraise the effect of treatment. Cysts from untreated pigs showed little variations between their basal and post treatment measures. At days 2 and 5 there were significant increases in GEI ratio compared with the untreated group (1.32 and 1.47 vs 1.01, p = 0.021 and p = 0.021). Cyst volume ratios were significantly lower at days 2 and 5 compared with the untreated group (0.60 and 0.22 vs 0.95, p = 0.04 and p = 0.02). Cysts with lower cyst volume ratios showed more marked post-treatment inflammation, loss of vesicular fluid and cyst wall wrinkling. CONCLUSION/SIGNIFICANCE: A significant and drastic reduction of cyst size and increased pericystic enhancement occur in the initial days after antiparasitic treatment as an effect of acute perilesional immune response. These significant changes showed that early anthelmintic efficacy (day two) can be detected using magnetic resonance imaging.

Indexed as

AlbendazoleAnimalsAnthelminticsBrainCystsDisease Models, AnimalDrug Therapy, CombinationFemaleMagnetic Resonance ImagingMaleNeurocysticercosisPraziquantelRadiographyRandom AllocationSwineSwine DiseasesAlbendazoleAnthelminticsPraziquantel

Identifiers

PMID28575043
PMCPMC5470720
OpenAlexW2620774152

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.